According to the death toll from COVID-19 They reach dizzying heightsCountries are racing to provide vaccines that can slow – and ultimately stop – the spread of the Coronavirus.
Success depends on a dizzying array of factors, from completing massive clinical trials so that vaccines still in development can be approved for use, to manufacturing and transporting billions of doses, ensuring that. Rich countries have no monopoly Vaccine supplies in the world, and most importantly, doses into people’s arms.
The charts and maps below will be updated to show the latest data on rolling out what will be the largest vaccination program in history, in the United States and around the world.
The vaccine rollout in the United States has been slower than expected so far. The Trump administration has set the bidding target 20 million vaccines By the end of 2020. This goal was not reached until late January. President Joe Biden has pledged to administer 100 million rounds in his first 100 days in office. Some experts said this Not fast enough.
There are marked differences from country to country in how quickly people are given vaccines. The two vaccines Agreed about Emergency use In the United States until now, they have been developed by companies Pfizer / Bioetec And the ModernIn two doses, several weeks apart. Some other vaccines that are still being prepared for approval only require one dose. So vaccinating every individual in the United States would ultimately require giving between 100 and 200 doses per 100 people in every state and territory – or between 330 million and 660 million doses for the entire nation. it’s a A huge logistical challenge.
Vaccines are distributed by the federal government to individual states. But as the map above shows, some states are managing vaccines delivered to them more quickly than others.
Search or browse this table to find how your state or territory is doing these key metrics for vaccine delivery.
Schedule for launching the vaccine
This graph shows the number of vaccines administered per 100 people per state as of the beginning of 2021. The top three states and the national numbers for the United States are highlighted. Type the name of any other US state or region into the search bar and select to add to the chart.
Launch of the vaccine by country
The United States is ahead of most other countries in launching the vaccine. But among the great powers, Israel was it The early leader. Search or browse this table to see how each country works.
This graph shows the number of vaccines that are administered per 100 people per country as of the beginning of 2021. Type the name of any country in the search bar and select to compare its schedule with the United States and the other three countries that top the list of vaccines around the world. Only countries that have started their vaccination campaigns will appear.
The pioneering vaccine case
This table documents the status of the leading COVID-19 vaccines, showing licenses for use in the United States and other large markets, as well as pricing from information related to purchase agreements. Collected by UNICEF, Where available.
The two leading vaccines to date, from Pfizer / BioNTech and Moderna, with clinical trial results indicating that they are more than 90% effective In the prevention of disease, on the basis of prof New technology It delivers a chain of RNA that causes our cells to produce viral proteins, which triggers an immune response.
The disadvantage is that these vaccines are more expensive than those made by linking the genetic material from the Coronavirus to an inactivated version of another virus, such as the one produced by the Anglo-Swedish company AstraZeneca, Based on research from Oxford UniversityAnd Russia Aesthetic Research Institute.
Other pioneering vaccines rely on inactivated versions of the Coronavirus, which is a long-term approach to making vaccines or protein subunits of the virus.
Jeremy Singer Fine contributed to writing this story.